NewsEvents

Your Yourlocation: Home > Tiotropium bromide(136310-93-5) and high-dose salmeterol fluticasone combination therapy

Recently, Shantou, Guangdong Province, Shantou people's livelihood Peng Weipeng and other research on the combination of severe bronchial asthma in patients with COPD efficacy and quality of life, the study found that tiotropium bromide(136310-93-5) and high-dose salmeterol and fluticasone combination therapy Can significantly improve lung function, relieve acute exacerbations, improve the quality of life, it is worth promoting. The article published in 2015 05 period "Chinese medicine science" on.

The aim of this study was to investigate the efficacy of tiotropium bromide(136310-93-5) and high-dose salmeterol and fluticasone in the treatment of bronchial asthma and COPD.

 METHODS: Seventy-one patients with bronchial asthma and patients with COPD were randomly divided into observation group (n = 36) and control group (n = 35). Patients in both groups were treated with conventional therapy. On this basis, Medium-dose salmeterol and fluticasone combination therapy, the observation group tiotropium bromide(136310-93-5) and high-dose salmeterol fluticasone combination therapy, compared the two groups of efficacy.

The results showed that there was no significant difference between the two groups in the ACT score before treatment and at 1, 6 and 12 months after treatment (P> 0.05). After 1 year of treatment, FEV1%, FEV1, △ PEF, time to onset, interval of onset, CAT score were significantly higher in the observation group than those in the control group (P <0.05).

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved